What is the prevalence of Sarcoidosis?

The prevalence of sarcoidosis varies significantly by population, but it is generally estimated to affect between 10 and 40 people per 100,000 in the general population, classifying it as a rare disease in many parts of the world.

Incidence and Demographics

Estimating the incidence of sarcoidosis is complex, as reported rates range from 1 to 35 per 100,000 individuals annually. While sarcoidosis can affect anyone, it displays distinct demographic patterns. It is most frequently diagnosed in adults between the ages of 20 and 40, though pediatric cases do occur and often present with more severe, systemic symptoms. Regarding gender, some clinical literature suggests a slightly higher prevalence in females, though this can vary by region.

Ethnic and Geographic Variations

The epidemiology of sarcoidosis is heavily influenced by ethnicity and geography. In the United States, the condition is notably more common and often more severe in African Americans compared to individuals of European descent. Similarly, high prevalence rates have been reported in Northern European populations, particularly in Scandinavia. These variations suggest that a combination of genetic predisposition and environmental triggers plays a critical role in the development of the disease.

Data Challenges and Real-World Insights

Accurate tracking of sarcoidosis remains a clinical challenge because the disease can be asymptomatic or present with non-specific symptoms, leading to significant underdiagnosis or misdiagnosis. Because many patients go undiagnosed for years, official public health statistics likely underestimate the true burden of the disease. At DiseaseMaps.org, our community of over 2,500 people living with sarcoidosis provides a vital, real-world perspective that complements clinical data, highlighting the daily lived experience of this complex condition beyond what is captured in traditional medical registries.

Medical Disclaimer: This information is for educational purposes and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• Foundation for Sarcoidosis Research (FSR)